M. Ceccon, Mologni, L., Bisson, W. H., Scapozza, L., and Gambacorti-Passerini, C.,
“Crizotinib-resistant NPM-ALK mutants confer differential sensitivity to unrelated Alk inhibitors”,
Molecular Cancer Research, vol. 11, pp. 122–132, 2013.
A. Goyer, Hasnain, G., Frelin, O., Ralat, M. A., Gregory, III, J. F., and Hanson, A. D.,
“A cross-kingdom Nudix enzyme that pre-empts damage in thiamin metabolism”,
Biochemical Journal, vol. 454, no. 10.1042/BJ20130516, 2013.
A. Goyer, Hasnain, G., Frelin, O., Ralat, M. A., Gregory, III, J. F., and Hanson, A. D.,
“A cross-kingdom Nudix enzyme that pre-empts damage in thiamin metabolism”,
Biochemical Journal, vol. 454, no. 10.1042/BJ20130516, 2013.
J. T. M. Buters, Mahadevan, B., Quintanilla-Martinez, L., Gonzalez, F. J., Greim, H., Baird, W. M., and Luch, A.,
“Cytochrome P450 1B1 Determines Susceptibility to Dibenzo[ a,l ]pyrene-Induced Tumor Formation”,
Chemical Research in Toxicology, vol. 15, no. 9, pp. 1127 - 1135, 2002.
J. T. M. Buters, Mahadevan, B., Quintanilla-Martinez, L., Gonzalez, F. J., Greim, H., Baird, W. M., and Luch, A.,
“Cytochrome P450 1B1 Determines Susceptibility to Dibenzo[ a,l ]pyrene-Induced Tumor Formation”,
Chemical Research in Toxicology, vol. 15, no. 9, pp. 1127 - 1135, 2002.
B. Lemaire, Kubota, A., O'Meara, C. M., Lamb, D. C., Tanguay, R. L., Goldstone, J. V., and Stegeman, J. J.,
“Cytochrome P450 20A1 in zebrafish: Cloning, regulation and potential involvement in hyperactivity disorders”,
Toxicology and Applied Pharmacology, vol. 296, pp. 73 - 84, 2016.